Skip to main content
Market intelligence
ETONHealthcare

Eton Pharmaceuticals Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 17, 2026Jennifer McKie AdamsCorporate insiderSale50,000$32.48$1,623,795
May 28, 2026Sean BrynjelsenPresident & CEOSale120,000$31.88$3,825,720
May 27, 2026David KrempaChief Business OfficerSale100,000$32.30$3,229,920